Tango Therapeutics, Inc. (TNGX) Ownership

$7.76

north_east
$0.07 (0.91%)
Day's range
$7.75
Day's range
$7.93

Tango Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TRV GP IV, LLC 11/13/2025 13.86 M $116.46 M   -17.77% 12.54%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2025 10.76 M $90.36 M   17.47% 9.73%
ECOR1 CAPITAL, LLC 11/14/2025 10.63 M $89.30 M   0.00% 9.62%
BOXER CAPITAL MANAGEMENT, LLC 11/14/2025 9.77 M $82.08 M   0.00% 8.84%
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 8.54 M $71.70 M   -20.49% 7.72%
WOODLINE PARTNERS LP 11/14/2025 6.03 M $50.65 M   0.00% 5.45%
SIREN, L.L.C. 11/13/2025 5.88 M $49.42 M   74.84% 5.32%
BLACKROCK, INC. 11/12/2025 5.65 M $47.43 M   3.36% 5.11%
NEXTECH INVEST, LTD. 11/14/2025 5.53 M $46.49 M   0.00% 5.01%
VANGUARD GROUP INC 11/07/2025 5.05 M $42.44 M   25.46% 4.57%
GILEAD SCIENCES, INC. 11/13/2025 4.85 M $40.78 M   0.00% 4.39%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2025 3.53 M $29.62 M   11.27% 3.19%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 3.47 M $29.17 M   6.92% 3.14%
STATE STREET CORP 11/14/2025 3.37 M $28.27 M   143.38% 3.04%
PARADIGM BIOCAPITAL ADVISORS LP 11/14/2025 3.09 M $25.92 M   100.00% 2.79%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 2.92 M $24.52 M   100.00% 2.64%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 11/14/2025 2.71 M $22.78 M   0.00% 2.45%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 2.51 M $21.09 M   -57.48% 2.27%
JANUS HENDERSON GROUP PLC 11/14/2025 2.30 M $19.32 M   100.00% 2.08%
RA CAPITAL MANAGEMENT, L.P. 11/14/2025 2.00 M $16.80 M   0.00% 1.81%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.88 M $15.82 M   6.44% 1.70%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 1.81 M $15.20 M   -47.38% 1.64%
GOLDMAN SACHS GROUP INC 11/14/2025 1.51 M $12.68 M   1,295.35% 1.37%
COMMODORE CAPITAL LP 11/14/2025 1.50 M $12.60 M   0.00% 1.36%
MARSHALL WACE, LLP 11/13/2025 1.49 M $12.51 M   -14.53% 1.35%
DEEP TRACK CAPITAL, LP 11/14/2025 1.45 M $12.22 M   100.00% 1.32%
MILLENNIUM MANAGEMENT LLC 11/14/2025 1.30 M $10.88 M   -26.91% 1.17%
INVESCO LTD. 11/13/2025 1.03 M $8.67 M   982.89% 0.93%
LOGOS GLOBAL MANAGEMENT LP 11/14/2025 950.00 K $7.98 M   100.00% 0.86%
NUVEEN, LLC 11/12/2025 928.01 K $7.80 M   109.50% 0.84%
FRANKLIN RESOURCES INC 11/13/2025 926.90 K $7.79 M   640.30% 0.84%
VIVO CAPITAL, LLC 11/14/2025 776.70 K $6.52 M   29.45% 0.70%
CANDRIAM S.C.A. 11/06/2025 708.81 K $5.95 M   0.00% 0.64%
BESSEMER GROUP INC 11/05/2025 708.40 K $5.95 M   0.00% 0.64%
ARROWMARK COLORADO HOLDINGS LLC 11/14/2025 708.39 K $5.95 M   0.00% 0.64%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 672.74 K $5.65 M   28.12% 0.61%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 658.29 K $5.53 M   9.45% 0.60%
NORTHERN TRUST CORP 11/14/2025 605.56 K $5.09 M   0.84% 0.55%
AVORO CAPITAL ADVISORS LLC 11/14/2025 545.00 K $4.58 M   100.00% 0.49%
D. E. SHAW & CO., INC. 11/14/2025 430.38 K $3.62 M   100.00% 0.39%
GREAT LAKES ADVISORS, LLC 11/03/2025 423.85 K $3.56 M   100.00% 0.38%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2025 384.21 K $3.23 M   100.00% 0.35%
BARCLAYS PLC 11/12/2025 365.68 K $3.07 M   163.74% 0.33%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 300.00 K $2.52 M   -58.90% 0.27%
ROYAL BANK OF CANADA 11/14/2025 287.50 K $2.42 M   13.96% 0.26%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 253.29 K $2.13 M   100.00% 0.23%
MORGAN STANLEY 11/14/2025 251.79 K $2.12 M   -52.90% 0.23%
STEMPOINT CAPITAL LP 11/14/2025 245.38 K $2.06 M   17.52% 0.22%
READYSTATE ASSET MANAGEMENT LP 11/07/2025 245.11 K $2.06 M   -41.43% 0.22%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2025 240.66 K $2.02 M   100.00% 0.22%

Tango Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 164 institutional investors and hedge funds held shares of Tango Therapeutics, Inc.. The most heavily invested institutionals were:

TRV GP IV, LLC: 13.86 M

FARALLON CAPITAL MANAGEMENT LLC: 10.76 M

EcoR1 Capital, LLC: 10.63 M

Boxer Capital Management, LLC: 9.77 M

TCG Crossover Management, LLC: 8.54 M

Woodline Partners LP: 6.03 M

126.63% of Tango Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 158.42 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.